Created in 1977 Ethypharm is one of the world leaders in the development and manufacturing of oral DDS (“Drug Delivery Systems”). The company supplies both major pharmaceutical groups and generics players with high-end drugs that feature particular absorption technologies. Drug Delivery Systems provide major benefits including improving the drug efficacy, enhancing patient compliance and comfort, extending the life cycle of existing drugs, and reducing the total cost of treatment.

With strong international exposure, the company employs 810 people in several production and R & D sites located in France, Canada, China and India. Their product portfolio currently includes about fifty specialties, sold to over 140 customers around the world.